BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16881527)

  • 1. [Legal and practical issues regarding collection and disclosure of prognostic data in population-based cancer registries].
    Tanaka H
    Nihon Koshu Eisei Zasshi; 2006 Jun; 53(6):391-7. PubMed ID: 16881527
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan.
    Tsukuma H; Ajiki W; Ioka A; Oshima A;
    Jpn J Clin Oncol; 2006 Sep; 36(9):602-7. PubMed ID: 16870692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparability and compatibility: issues in combining data from central cancer registries.
    Howe HL
    Top Health Inf Manage; 1997 Feb; 17(3):29-34. PubMed ID: 10165385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and use of the North American Association of Central Cancer Registries standards for cancer registries.
    Seiffert JE
    Top Health Inf Manage; 1997 Feb; 17(3):35-44. PubMed ID: 10165386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries.
    Ajiki W; Tsukuma H; Oshima A;
    Jpn J Clin Oncol; 2004 Jun; 34(6):352-6. PubMed ID: 15333689
    [No Abstract]   [Full Text] [Related]  

  • 6. Partial cancer prevalence in Japan up to 2020: estimates based on incidence and survival data from population-based cancer registries.
    Tabata N; Ohno Y; Matsui R; Sugiyama H; Ito Y; Tsukuma H; Oshima A
    Jpn J Clin Oncol; 2008 Feb; 38(2):146-57. PubMed ID: 18245517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of extrapolating data in tumor registries. An instrument for a deeper knowledge of epidemiology].
    Cappelluti G; Busilacchi P
    Minerva Med; 1987 Jun; 78(11):775-6. PubMed ID: 3587725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological data sources in Estonia: a survey of registries and databases.
    Innos K; Rahu M
    J Epidemiol Biostat; 2000; 5(5):293-302. PubMed ID: 11142605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer incidence and incidence rates in Japan in 1987: estimates based on data from nine population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan.
    Jpn J Clin Oncol; 1992 Dec; 22(6):437-42. PubMed ID: 1291762
    [No Abstract]   [Full Text] [Related]  

  • 10. Legal regulation of cancer surveillance: Canadian and international perspectives.
    von Tigerstrom B; DeschĂȘnes M; Knoppers BM; Caulfield TA
    Health Law J; 2000; 8():1-94, i-xxxiv. PubMed ID: 11398220
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving the quality of industry and occupation data at a central cancer registry.
    Armenti KR; Celaya MO; Cherala S; Riddle B; Schumacher PK; Rees JR
    Am J Ind Med; 2010 Oct; 53(10):995-1001. PubMed ID: 20860053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking data from hospital and cancer registry databases: should this be standard practice?
    Field K; Kosmider S; Johns J; Farrugia H; Hastie I; Croxford M; Chapman M; Harold M; Murigu N; Gibbs P
    Intern Med J; 2010 Aug; 40(8):566-73. PubMed ID: 19460066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assuring the quality of cancer registration in Rhode Island. Evaluation of early returns indicates future measures for enhancing reliability.
    Fulton JP; Buechner JS; Stanis D; Raimondo M
    R I Med J (1976); 1988 Sep; 71(9):337-46. PubMed ID: 3187325
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparability of colorectal cancer survival data in three European population-based registries.
    Monnet E; Faivre J; Raymond L; Garau I
    Eur J Cancer Prev; 1998 Apr; 7(2):127-34. PubMed ID: 9818774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic differences in cancer survival: a review of the evidence.
    Kogevinas M; Porta M
    IARC Sci Publ; 1997; (138):177-206. PubMed ID: 9353665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project.
    Matsuda T; Marugame T; Kamo K; Katanoda K; Ajiki W; Sobue T;
    Jpn J Clin Oncol; 2011 Jan; 41(1):139-47. PubMed ID: 20819836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer incidence and incidence rates in Japan in 1988: estimates based on data from ten population-based Cancer Registries. The Research Group for Population-based cancer registration in Japan.
    Jpn J Clin Oncol; 1994 Oct; 24(5):299-304. PubMed ID: 7967110
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer incidence and incidence rates in Japan in 2004: based on data from 14 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project.
    Matsuda T; Marugame T; Kamo K; Katanoda K; Ajiki W; Sobue T;
    Jpn J Clin Oncol; 2010 Dec; 40(12):1192-200. PubMed ID: 20647231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistics on survival from Osaka Cancer Registry.
    Tsukuma H; Ajiki W; Oshima A
    Jpn J Cancer Res; 1998 Oct; 89(10):inside front cover. PubMed ID: 9874599
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer incidence and incidence rates in Japan in 1986: estimates based on data from nine population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan.
    Jpn J Clin Oncol; 1991 Aug; 21(4):318-23. PubMed ID: 1942562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.